Our mission is to develop disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases to address the unmet medical need.
-
Highlight
Herantis Pharma receives research funding from The Michael J. Fox Foundation, US and the Parkinson's Virtual Biotech, UK
-
Highlight
Herantis Pharma, Webcast, Q2’24